Stephen Paul Story;Claude Jarakae Jensen;Mian Ying Wang;Afa Kehaati Palu;Chen Xing Su;Bing-Nan Zhou;Brett Justin West;Johannes Joseph Westendorf
发明人:
Mian Ying Wang,Chen Xing Su,Afa Kehaati Palu,Bing-Nan Zhou,Brett Justin West,Johannes Joseph Westendorf,Claude Jarakae Jensen,Stephen Paul Story
申请号：
US10808872
公开号：
US08501245B2
申请日:
2004.03.24
申请国别(地区):
US
年份:
2013
代理人:
摘要：
Implementation is directed to selectively inhibiting estrogen production and providing estrogenic effects in a human body. A dietary supplement includes a processed Morinda citrifolia product that is used to inhibit aromatase or aromatase enzymes that function to convert androgens to estrogens, inhibit receptors from binding with estrogen, and reduce and/or regulate estrogen production, as well as reduce the amount of estrogen produced within the body and regulating such production. The dietary supplement further provides estrogenic effects. The present invention methods and compositions effectively function to treat estrogen-dependent cancers, and particularly inhibit, destroy, and reverse the effects of of estrogen-dependent cancerous tumors through the introduction into the body (e.g. ingesting) a safe, pre-determined dosage of a naturaceutical composition formulated with or comprising one or more processed Morinda citrifolia products for a safe, pre-determined duration.
